Natural Shikonin Potentially Alters Intestinal Flora to Alleviate Acute Inflammation
Microorganisms · 23.08.2023 · 11 (9) · 2139
DOI: 10.3390/microorganisms11092139 ↗Kurz gefasst
Fachartikel in der Zeitschrift Microorganisms, online erschienen am 23.08.2023. Verfasst von Ying Liang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Precision Pharmacy & Drug Development Center, Department of Pharmacy, Tangdu Hospital, Fourth Military Medical University, Xi'an 710038, China. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: "Phoenix Introduction Plan" Talent Startover Project of Tangdu Hospital, Fourth Military Medical University, “Phoenix Introduction Plan” Talent Startover Project of Tangdu Hospital, Fourth Military Medical University, National Natural Science Foundation of China.
Abstract (Originalsprache)
Shikonin, derived from the herb Lithospermum erythrorhizon (Purple Cromwell), is extensively utilized in traditional Chinese medicine as an anti-inflammatory agent; however, its effect on the intestinal flora is not yet known. Herein, we demonstrate that, compared to a blank control group, the intragastric administration of shikonin suppressed the swelling rate of ears in a mouse model of acute inflammation in a dose-dependent manner via animal experiments; furthermore, the 20 mg/kg shikonin treatment exhibited the highest inhibitory effect. In formal animal experimentation, we discovered that the inhibitory effect of shikonin with 20 mg/kg on inflammation was closely linked to the intestinal flora, whereby the microbiota phylum was altered in feces through a 16S rDNA sequencing analysis, implying that shikonin improves gut microbiota structures and compositions to counteract inflammation. Notably, using a real-time quantitative polymerase chain reaction (RT-qPCR), a Western blotting assay, and an immunohistochemistry (IHC) assay, we found that inflammatory cytokines such as TNF-α, IL-6, and IL-1β reduced in both the shikonin-administration group and the positive control group than those in the blank control group, as expected. To the best of our knowledge, this is the first study to outline the underlying mechanism through which shikonin acts on gut microbes to alleviate acute inflammation, providing an alternative mechanism for shikonin to become a preventive agent in countering inflammation.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Precision Pharmacy & Drug Development Center, Department of Pharmacy, Tangdu Hospital, Fourth Military Medical University, Xi'an 710038, China.
- Department of Urology, Xijing Hospital, Fourth Military Medical University, Xi'an 710032, China.
- Department of Oncology, The First Affiliated Hospital, School of Medicine, Xi'an Jiaotong University, Xi'an 710086, China.
ORCID-Profile: Wenna Liu
Förderung
- "Phoenix Introduction Plan" Talent Startover Project of Tangdu Hospital, Fourth Military Medical University
- “Phoenix Introduction Plan” Talent Startover Project of Tangdu Hospital, Fourth Military Medical University
- National Natural Science Foundation of China
Zitieren
APA
Liang, Y., Ju, D., Liu, W., Wu, D., Zhao, Y., Du, Y., Li, X., & Zhao, M. (2023). Natural Shikonin Potentially Alters Intestinal Flora to Alleviate Acute Inflammation. Microorganisms, 11(9), 2139. https://doi.org/10.3390/microorganisms11092139
Vancouver
Liang Y, Ju D, Liu W, Wu D, Zhao Y, Du Y, et al. Natural Shikonin Potentially Alters Intestinal Flora to Alleviate Acute Inflammation. Microorganisms. 2023;11(9):2139. doi:10.3390/microorganisms11092139
BibTeX
@article{Liang2023,
author = {Liang, Ying and Ju, Dongen and Liu, Wenna and Wu, Dan and Zhao, Yujia and Du, Yaya and Li, Xi and Zhao, Minggao},
title = {Natural Shikonin Potentially Alters Intestinal Flora to Alleviate Acute Inflammation},
journal = {Microorganisms},
year = {2023},
volume = {11},
number = {9},
pages = {2139},
doi = {10.3390/microorganisms11092139}
}
EUVIMED